Report overview
This report contains market size and forecasts of Hepatitis B Therapeutics in Global, including the following market information:
Global Hepatitis B Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hepatitis B Therapeutics market was valued at 2563.9 million in 2021 and is projected to reach US$ 3125.7 million by 2028, at a CAGR of 2.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hepatitis B Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis B Therapeutics include GlaxoSmithKline, Bristol-Myers Squibb, Novira Therapeutics, Johnson & Johnson, Abivax, F. Hoffmann- La Roche, Novartis and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis B Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis B Therapeutics Market Segment Percentages, by Type, 2021 (%)
Hepatitis B Vaccine
Anti-viral Drugs
Global Hepatitis B Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis B Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Hepatitis B Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hepatitis B Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hepatitis B Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Bristol-Myers Squibb
Novira Therapeutics
Johnson & Johnson
Abivax
F. Hoffmann- La Roche
Novartis
Merck
